We are international
Donate
• IMF TV TEXT SIZE   
webcasts from medical meetings    back

Dr. Kaufman - ASH 2008 - First Trial of Humanized Anti-CD74 Monoclonal Antibody (MAb), Milatuzumab, in Multiple Myeloma
Jonathan Kaufman, MD
Emory University School of Medicine
Winship Cancer Institute
Atlanta Georgia
USA
12.28.08

Be the first to comment

 related articles